Trials that use: ANCOVA
New to this method? Read the tutorial →
3,370 results
- Performance Evaluation of Different Daily Disposable Silicone Hydrogel Contact Lenses: Complete Statistical AnalysisIndependent statistical analysis of Performance Evaluation of Different Daily Disposable Silicone Hydrogel Contact Lenses: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05805059).
- Performance of Wearers of Stenfilcon A Contact Lenses After A Refit With Test Lenses: Complete Statistical AnalysisIndependent statistical analysis of Performance of Wearers of Stenfilcon A Contact Lenses After A Refit With Test Lenses: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- PerformsIndependent statistical analysis of A Multicenter, Open-label, RebiSmart™ Autoinjector Ease of Use Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01036165).
- PERFUSEIndependent statistical analysis of Multicenter, Nonrandomized, Prospective Study of Pulmonary Embolism Removal With the AngioJet 6F Ultra System: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Peri-implantitis Treatment: Clinical Results of Conventional Treatment vs. the Addition of Biolase: Complete Statistical AnalysisIndependent statistical analysis of Peri-implantitis Treatment: Clinical Results of Conventional Treatment vs. the Addition of Biolase: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Perioperative Use of Gabapentin To Decrease Narcotic Requirements in Spinal Fusion: Complete Statistical AnalysisIndependent statistical analysis of Perioperative Use of Gabapentin To Decrease Narcotic Requirements in Spinal Fusion: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Peripheral Dopamine in Postural Tachycardia Syndrome: Complete Statistical AnalysisIndependent statistical analysis of Peripheral Dopamine in Postural Tachycardia Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00685919).
- Peripheral Nerve Ultrasound for Diagnosis and Prognosis of Guillain-Barre Syndrome: Complete Statistical AnalysisIndependent statistical analysis of Peripheral Nerve Ultrasound for Diagnosis and Prognosis of Guillain-Barre Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04053452).
- PERSISTIndependent statistical analysis of Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01358357).
- PersistIndependent statistical analysis of Psychosocial Pain Management to Improve Opioid Use Disorder Treatment Outcomes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04433975).
- PERSIST-AVRIndependent statistical analysis of Perceval Sutureless Implant Versus Standard-Aortic Valve Replacement: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02673697).
- Personalized Feedback for Distress Intolerant Smokers: Complete Statistical AnalysisIndependent statistical analysis of Personalized Feedback for Distress Intolerant Smokers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03918031).
- Personalized Therapeutic Neuromodulation for Anhedonic Depression: Complete Statistical AnalysisIndependent statistical analysis of Personalized Therapeutic Neuromodulation for Anhedonic Depression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05144789).
- Personalizing MPK Prescription: Complete Statistical AnalysisIndependent statistical analysis of Personalizing MPK Prescription: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06399471).
- Personalizing Sleep Interventions to Prevent Type 2 Diabetes in Community Dwelling Adults With Pre-Diabetes: Complete Statistical AnalysisIndependent statistical analysis of Personalizing Sleep Interventions to Prevent Type 2 Diabetes in Community Dwelling Adults With Pre-Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- PET Imaging of the Dopaminergic and Serotonergic Systems in Treated HIV Positive Subjects: Complete Statistical AnalysisIndependent statistical analysis of PET Imaging of the Dopaminergic and Serotonergic Systems in Treated HIV Positive Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- PET-CRAIndependent statistical analysis of Imaging the Neurobiology of a Behavioral Treatment for Cocaine Dependence: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00376558).
- PFA and SPFIndependent statistical analysis of Determination of Sun Protection in Sunscreen Formulas (Study SR09-15)(P08236)(COMPLETED): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01001975).
- PFAS Exposure and Immune Response to Vaccination in Adults: Complete Statistical AnalysisIndependent statistical analysis of PFAS Exposure and Immune Response to Vaccination in Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06588530).
- Pharmacodynamic Biomarkers to Support Biosimilar Development: PCSK9 Inhibitors: Complete Statistical AnalysisIndependent statistical analysis of Pharmacodynamic Biomarkers to Support Biosimilar Development: PCSK9 Inhibitors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04189484).
- Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma.: Complete Statistical AnalysisIndependent statistical analysis of Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Pharmacogenetic Treatment With Anti-Glutaminergic Agents for Comorbid PTSD & AUD: Complete Statistical AnalysisIndependent statistical analysis of Pharmacogenetic Treatment With Anti-Glutaminergic Agents for Comorbid PTSD & AUD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02884908).
- Pharmacogenetics of Alcohol: Treatment Implications: Complete Statistical AnalysisIndependent statistical analysis of Pharmacogenetics of Alcohol: Treatment Implications: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00734656).
- Pharmacogenomics of the Variability in the In Vivo Response to Glucocorticoids: Complete Statistical AnalysisIndependent statistical analysis of Pharmacogenomics of the Variability in the In Vivo Response to Glucocorticoids: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Pharmacokinetic and Exploratory Electrocardiogram (ECG) Study: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetic and Exploratory Electrocardiogram (ECG) Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01018420).
- Pharmacokinetic Study of 4 mg Nicotine Lozenge.: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetic Study of 4 mg Nicotine Lozenge.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01669122).
- Pharmacokinetic Study of AG200-15 Transdermal Patch to Three Anatomical Sites in Healthy Females: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetic Study of AG200-15 Transdermal Patch to Three Anatomical Sites in Healthy Females: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Pharmacokinetic Study of Liposomal Vincristine in Patients With Malignant Melanoma & Hepatic Dysfunction: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetic Study of Liposomal Vincristine in Patients With Malignant Melanoma & Hepatic Dysfunction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Pharmacokinetic, Efficacy and Safety Study of Tapentadol Oral Solution in Children With Postoperative Pain: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetic, Efficacy and Safety Study of Tapentadol Oral Solution in Children With Postoperative Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Pharmacokinetic/Pharmacodynamic Study of Doripenem in Febrile Neutropenic Patients: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetic/Pharmacodynamic Study of Doripenem in Febrile Neutropenic Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01401010).
- Pharmacokinetics and Excretion of [¹⁴C]Etelcalcetide (AMG 416) in Patients With End Stage Renal Disease (ESRD) Receiving Dialysis: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetics and Excretion of [¹⁴C]Etelcalcetide (AMG 416) in Patients With End Stage Renal Disease (ESRD) Receiving Dialysis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Pharmacokinetics and Pharmacodynamics of Dexmedetomidine in Pediatrics Subjects: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetics and Pharmacodynamics of Dexmedetomidine in Pediatrics Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00652028).
- Pharmacokinetics and Safety of Bupivacaine HCl Spinal Block and EXPAREL Local Infiltration in Total Knee Arthroplasty: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetics and Safety of Bupivacaine HCl Spinal Block and EXPAREL Local Infiltration in Total Knee Arthroplasty: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Pharmacokinetics of a Single Treatment Cycle of AA4500 0.58 mg in Men With Peyronie’s Disease: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetics of a Single Treatment Cycle of AA4500 0.58 mg in Men With Peyronie's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Pharmacokinetics of Advantage Anti-Caries Varnish: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetics of Advantage Anti-Caries Varnish: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04183231).
- Pharmacokinetics of Ceftolozane/Tazobactam in Patients With Burns: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetics of Ceftolozane/Tazobactam in Patients With Burns: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03002506).
- Pharmacokinetics of Daptomycin During Cardiopulmonary Bypass Surgery: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetics of Daptomycin During Cardiopulmonary Bypass Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00701636).
- Pharmacokinetics of Entospletinib in Adults With Normal and Impaired Liver Function: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetics of Entospletinib in Adults With Normal and Impaired Liver Function: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Pharmacokinetics of Omadacycline in Cystic Fibrosis: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetics of Omadacycline in Cystic Fibrosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04460586).
- Pharmacokinetics of Sugammadex (MK-8616) in Participants With Moderate and Severe Renal Insufficiency (MK-8616-105): Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetics of Sugammadex (MK-8616) in Participants With Moderate and Severe Renal Insufficiency (MK-8616-105): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Pharmacokinetics of Vitamin D in Multiple Sclerosis and in Health: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetics of Vitamin D in Multiple Sclerosis and in Health: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01667796).
- Pharmacokinetics, Pharmacodynamics, and Impact of Inorganic Nitrate on Exercise in HFpEF: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetics, Pharmacodynamics, and Impact of Inorganic Nitrate on Exercise in HFpEF: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Pharmacokinetics, Subjective Effects, and Abuse Liability of Nicotine Salt-Based Vaping Products With Tobacco or Unflavored E-liquids, SALTVAPE Study: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetics, Subjective Effects, and Abuse Liability of Nicotine Salt-Based Vaping Products With Tobacco or Unflavored E-liquids, SALTVAPE Study: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Pharmacological Effects of Crushing Prasugrel in STEMI Patients: Complete Statistical AnalysisIndependent statistical analysis of Pharmacological Effects of Crushing Prasugrel in STEMI Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02212028).
- PHASEIndependent statistical analysis of Effects of Sulforaphane on Normal Prostate Tissue: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00946309).
- Phase 1 Study to Determine the Effects of Food on the Pharmacokinetic Profile of PBT2: Complete Statistical AnalysisIndependent statistical analysis of Phase 1 Study to Determine the Effects of Food on the Pharmacokinetic Profile of PBT2: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Phase 1b/2a Study to Evaluate Safety and Efficacy of Setmelanotide in Obese Patients: Complete Statistical AnalysisIndependent statistical analysis of Phase 1b/2a Study to Evaluate Safety and Efficacy of Setmelanotide in Obese Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Phase 2 Chronic Low Back Pain Study: Complete Statistical AnalysisIndependent statistical analysis of Phase 2 Chronic Low Back Pain Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01364922).
- Phase 2 Clinical Trial of SGS-742 Therapy in Succinic Semialdehyde Dehydrogenase Deficiency: Complete Statistical AnalysisIndependent statistical analysis of Phase 2 Clinical Trial of SGS-742 Therapy in Succinic Semialdehyde Dehydrogenase Deficiency: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Phase 2 Healthy Volunteer Study to Evaluate the Ability of PRT064445 to Reverse the Effects of Several Blood Thinner Drugs on Laboratory Tests (Module 3 of 4): Complete Statistical AnalysisIndependent statistical analysis of Phase 2 Healthy Volunteer Study to Evaluate the Ability of PRT064445 to Reverse the Effects of Several Blood Thinner Drugs on Laboratory Tests (Module 3 of 4): primary…